Argent inks binding agreement to buy AusCann’s CannPal stake by Adam Sheldon January 15, 2026January 15, 2026 Argent BioPharma has signed a binding agreement with AusCann Group Holdings to acquire its 48% interest […]
Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025
Argent Biopharma and Auscann sign deal to ‘enhance drug development’ by Steve Jones April 23, 2025April 23, 2025
News in brief: Rua’s German stock shortage; Zelira’s finance deal; cultivator nets $1.4m; Neurotech exec steps down; ‘major milestone’ for Argent; Cann Group pharmacy deal by Steve Jones and Martin Lane April 3, 2025April 3, 2025
Company news: MGC Pharma; Neurotech International; Incannex Healthcare by Martin Lane June 1, 2023April 30, 2024
Company news: MedReleaf; Vitura Health; MGC Pharma; Rua Bioscience by Martin Lane April 13, 2023April 30, 2024
Company news: MGC Pharma; AusCann; Creso Pharma; Canopy Growth by Martin Lane September 16, 2021April 26, 2024
